NICE opens a technology appraisal project for retatrutide

Regulator record

NICE has opened a technology appraisal project record for retatrutide: “Retatrutide for managing overweight and obesity [ID6644]”, reference GID-TA11845. Current status: awaiting development — the earliest pipeline stage, before scoping or committee work has begun. No expected publication date has been set.

ConfirmedNICE has opened a project record for retatrutide (GID-TA11845) — the earliest pipeline stage, confirming NICE is tracking the drug for a future appraisal.

Not establishedThis does not mean retatrutide has a UK marketing authorisation, an active appraisal timetable, or a scoping/committee date — 'awaiting development' has no confirmed next step scheduled.

Source: NICE · checked 2026-08-08

Checked 2026-08-08 · next review due 2026-11-08

← Back to the Record